Healthcare leads Europe lower
STOXX 600 down 0.6%
Healthcare lags
GSK, Sanofi fall on RFK Jr. nomination
Wall St futures lower
Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com
HEALTHCARE LEADS EUROPE LOWER
A fall in healthcare stocks is leading major European stock indexes lower on Friday, with vaccine markers hit particularly hard after Trump nominated RFK Jr. to lead the top U.S. health body.
Kennedy has been criticized for making false medical claims, including that vaccines are linked to autism.
European-listed vaccine makers - GSK GSK.L, Sanofi SASY.PA and Biontech 22UAy.DE among others - are lower by between 3.3%-9%.
Overall, the healthcare subsector .SXDP is underperforming, down 2.2%, compared to a 0.7% drop for the broader STOXX 600 .STOXX.
The index is on track to end a choppy week down by about 0.5%.
Switzerland's SMI .SSMI, which has a heavy weighting towards healthcare stocks, is the worst performing major bourse in Europe, falling about 1%.
In other corporate news, Evotec EVTG.DE shares are surging almost 18% after the company received a takeover approach from Halozyme Therapeutics HALO.O.
Here's your opening snapshot:
(Samuel Indyk)
*****
FRIDAY'S OTHER LIVE MARKETS POSTS:
EUROPEAN STOCK FUTURES HEAD SOUTH CLICK HERE
CHINESE CONSUMERS SPEND MORE, JUST NOT ON PROPERTY CLICK HERE
China's mixed October data keeps stimulus calls alive https://reut.rs/3YPXD6v
European shares mostly lower https://reut.rs/3AJ3t1h
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
